Borealis Ventures Leads Series A for Avitide
New Hampshire-based biotech startup Avitide Inc. has raised an undisclosed amount of Series A financing from Borealis Ventures, SV Life Sciences, Polaris Venture Partners, OrbiMed Advisors, and Angeli Parvi. Borealis led the round. Phil Ferneau of Borealis Ventures, and Michael Ross of SV Life Sciences, joined Avitide’s board. The company is focused on the development of “custom affinity purification solutions” for the biopharmaceutical industry.
15 March 2013•4 mins read
